Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Chest
    November 2026
  1. TAN Q, Huang CC, Becerra MC, Calderon R, et al
    Pragmatic Clinical indicators of Tuberculosis Transmission Risk: a Household Contact Cohort Study.
    Chest. 2026 Nov 11:S0012-3692(26)06963-1. doi: 10.1016/j.chest.2026.
    >> Share

  2. SINHA P, Karoly M, Gaikwad S, Luke EH, et al
    The Impact of Undernutrition on Post-Tuberculosis Lung-Function: A Prospective Cohort Study.
    Chest. 2026 Nov 5:S0012-3692(26)06953-9. doi: 10.1016/j.chest.2026.
    >> Share

    September 2026
  3. WALSH J, Hsu JY, Tully E, Hong G, et al
    Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Chest. 2026 Sep 30:S0012-3692(26)06775-9. doi: 10.1016/j.chest.2026.
    >> Share

  4. GIBERT C, Maitre T, Godet C, Debray MP, et al
    Time-Normalized Anti-Aspergillus IgG Kinetics for Monitoring Chronic Pulmonary Aspergillosis Progression.
    Chest. 2026 Sep 21:S0012-3692(26)06667-5. doi: 10.1016/j.chest.2026.
    >> Share

  5. KIM DH, Jung S, Jung S, Kim JY, et al
    Phylogenomic and Clinical Perspectives of an East Asia-Specific Cluster of Mycobacterium massiliense.
    Chest. 2026;170:701-713.
    >> Share

    July 2026
  6. RIVARD R, Mailhot-Larouche S, Borg C, Pujan P, et al
    Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleurkin-5 Biologics.
    Chest. 2026;170:e1-e4.
    >> Share

  7. ARBIV OA, Postill G, Im Y, Jhun BW, et al
    Antimicrobial Treatment of Mild Mycobacterium avium Complex Pulmonary Disease Predicted to Increase Survival and Quality-Adjusted Life Years: A Microsimulation Decision Analysis Model.
    Chest. 2026;170:66-75.
    >> Share

    June 2026
  8. PEREZ MA, Hoffmann WJ, Perez JC, Adelman MW, et al
    Invasive Candidiasis in Critically Ill Patients: Fundamental Concepts and Future Directions.
    Chest. 2026;169:1561-1574.
    >> Share

  9. LIEU A, Mah JK, Vinh DC, Qureshi ST, et al
    Pulmonary Fungal Infections in the Immunocompetent Host.
    Chest. 2026;169:1506-1523.
    >> Share

    May 2026
  10. SERRANO-MAYORGA CC, Olivella-Gomez J, Sanabria-Herrera N, Nseir S, et al
    Pseudomonas aeruginosa in Patients With Nosocomial Respiratory Infections: A Secondary Analysis of the European Network for ICU-Related Respiratory Infections.
    Chest. 2026;169:1240-1254.
    >> Share

    April 2026
  11. PENNINGTON KM, Heien H, Yadav H, El Mokahal A, et al
    Impact of Invasive Mold Infection-Coded Diagnoses on Utilization, Costs, and Mortality After Lung Transplantation.
    Chest. 2026 Apr 28:S0012-3692(26)00564-7. doi: 10.1016/j.chest.2026.
    >> Share

  12. REIZINE F, Feys S, Seidel D, Mauget M, et al
    Effects of antifungal treatment in COVID-19-associated pulmonary aspergillosis: A European multicenter cohort study.
    Chest. 2026 Apr 17:S0012-3692(26)00448-4. doi: 10.1016/j.chest.2026.
    >> Share

    March 2026
  13. SEO C, Dumoulin E, Thornton CS
    Spore Wars: A Comprehensive Review of Pulmonary Aspergilloma and Its Clinical Management.
    Chest. 2026 Mar 12:S0012-3692(26)00295-3. doi: 10.1016/j.chest.2026.
    >> Share

  14. KATAGIRA W, Orme MW, Kasiita R, Matheson JA, et al
    Clinical and cost-effectiveness of pulmonary rehabilitation for people with post-tuberculosis lung disease in Uganda: a randomised controlled trial.
    Chest. 2026 Mar 6:S0012-3692(26)00273-4. doi: 10.1016/j.chest.2025.
    >> Share

  15. VYAS YK
    17-Year-Old Male Patient With Pulmonary TB Presenting With Tingling and Numbness in the Left Upper Limb.
    Chest. 2026;169:e103-e107.
    >> Share

  16. PULSIPHER AM, Vikram HR, Gotway MB, Cartin-Ceba R, et al
    Adjunctive Corticosteroid Use and Clinical Outcomes in Non-HIV Pneumocystis jirovecii Pneumonia.
    Chest. 2026;169:616-625.
    >> Share

    February 2026
  17. JO KW, Lee JB, Lee J, Lee HN, et al
    Impact of Treatment Outcome on Mortality in Mycobacterium abscessus Complex Pulmonary Disease.
    Chest. 2026;169:349-359.
    >> Share

    January 2026
  18. ZHA BS, Ieong M, Cheng I, Bokser S, et al
    Formation and Growth of a Bronchiectasis and Pulmonary NTM Multidisciplinary Program Using a Patient-Centered and Integrated Care Model Improves Outcomes.
    Chest. 2026 Jan 12:S0012-3692(25)05831-3. doi: 10.1016/j.chest.2025.
    >> Share

  19. METERSKY ML, Hunt CR, Addrizzo-Harris DJ, Aksamit TR, et al
    The Bronchiectasis and Non-Tuberculous Mycobacterial Care Center Network: Improving Access and Quality of Care.
    Chest. 2026;169:34-36.
    >> Share

    December 2025
  20. FLUME P, Bullington W, Christon L, Crawford E, et al
    Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM Association.
    Chest. 2025 Dec 18:S0012-3692(25)05928-8. doi: 10.1016/j.chest.2025.
    >> Share

  21. TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
    Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
    Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
    >> Share

    September 2025
  22. SINHA P, Karoly M, Padmapriyadarsini C, Paradkar M, et al
    Contribution of Key Comorbidities to Unfavorable Treatment Outcomes among Adults with Drug-sensitive Pulmonary Tuberculosis in India: a Prospective Cohort Analysis.
    Chest. 2025 Sep 10:S0012-3692(25)05171-2. doi: 10.1016/j.chest.2025.
    >> Share

    July 2025
  23. CHEN C, Xue H, Horsburgh CR, Amour M, et al
    Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.
    Chest. 2025;168:33-42.
    >> Share

    May 2025
  24. JIANG J, Rao Y, Liu C, Chang SJ, et al
    A 7-Year-Old Girl With Multiple Pulmonary Nodules.
    Chest. 2025;167:e161-e165.
    >> Share

  25. DONOVAN FM, Thompson GR 3rd, Blair JE, Johnson RH, et al
    Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.
    Chest. 2025;167:1311-1320.
    >> Share

    April 2025
  26. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    >> Share

  27. CARTER C, Shah A
    The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
    Chest. 2025;167:914-916.
    >> Share

    March 2025
  28. LEE J, Park SJ, Kim S, Lee HN, et al
    Isolation of Genetically Distinct Strains Within the Same Species During Treatment of Mycobacterium Avium Complex Pulmonary Disease.
    Chest. 2025;167:675-685.
    >> Share

    February 2025
  29. JAIN R, Peng G, Lee M, Keller A, et al
    Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
    Chest. 2025;167:348-361.
    >> Share

  30. WAHAB A, Sanborn D, Vergidis P, Razonable R, et al
    Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host.
    Chest. 2025;167:374-386.
    >> Share

    January 2025
  31. KIM H, Jo E, Kim J, Lee N, et al
    Diagnostic Performance of the Modified Lung-RADS in a Tuberculosis-endemic Country: The Korean National Lung Cancer Screening Program.
    Chest. 2025 Jan 28:S0012-3692(25)00133-3. doi: 10.1016/j.chest.2025.
    >> Share

  32. JIANG Y, Huang X, Zhou H, Wang M, et al
    Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study.
    Chest. 2025;167:54-66.
    >> Share

    December 2024
  33. EVEN-DAR R, Raz I, Brodsky M, Stein N, et al
    Non- Tuberculous mycobacterial infection and pulmonary disease In Northern Israel: a focus on M. simiae.
    Chest. 2024 Dec 2:S0012-3692(24)05600-9. doi: 10.1016/j.chest.2024.
    >> Share

    November 2024
  34. HOLTROP M, Cosmich S, Lee M, Keller A, et al
    Sex Differences After Treatment With Ivacaftor in People With Cystic Fibrosis.
    Chest. 2024;166:951-962.
    >> Share

    October 2024
  35. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    >> Share

  36. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    >> Share

  37. GABORIT B, Lecuyer R, Issa N, Camou F, et al
    Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
    Chest. 2024;166:708-711.
    >> Share

  38. JOEAN O, von Eynern LP, Welte T, Einecke G, et al
    Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
    Chest. 2024;166:697-707.
    >> Share

    September 2024
  39. LEE JK, Kim S, Chong YP, Lee HJ, et al
    The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2024;166:442-451.
    >> Share

  40. HYUNG K, Kim SA, Kim JY, Kwak N, et al
    Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: Secondary Analysis of a Prospective Cohort Study.
    Chest. 2024;166:452-460.
    >> Share

    August 2024
  41. PEDERSEN AA, Lokke A, Floe A, Ibsen R, et al
    Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up.
    Chest. 2024;166:271-280.
    >> Share

    July 2024
  42. BAI AD, Srivastava S, Digby GC, Girard V, et al
    Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms: A Retrospective Cohort Study.
    Chest. 2024;166:39-48.
    >> Share

  43. FELZER JR, Montgomery AJ, LeMahieu AM, Finney Rutten LJ, et al
    Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.
    Chest. 2024;166:49-60.
    >> Share

    June 2024
  44. SCHERGER SJ, Kalil AC
    Changes in the Mortality Rate and Epidemiology of Pneumocystis Pneumonia Require Novel Approaches to Clinical Care.
    Chest. 2024;165:1273-1275.
    >> Share

  45. LECUYER R, Issa N, Camou F, Lavergne RA, et al
    Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
    Chest. 2024;165:1319-1329.
    >> Share

    May 2024
  46. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    >> Share

    March 2024
  47. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    >> Share

  48. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    >> Share

  49. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    >> Share

  50. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    >> Share

    December 2023
  51. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    >> Share

  52. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016